Cargando…
MicroRNA expression analysis during FK506-induced osteogenic differentiation in rat bone marrow stromal cells
FK506 (also known as tacrolimus) is a potent immunosuppressive agent that is widely used in the treatment of graft-rejection and autoimmune diseases. FK506 has attracted additional attention owing to its potential role in osteogenic differentiation and bone formation. MicroRNAs (miRNAs) have been de...
Autores principales: | Zhang, Jing, Yu, Xiaoping, Yu, Youcheng, Gong, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482066/ https://www.ncbi.nlm.nih.gov/pubmed/28560399 http://dx.doi.org/10.3892/mmr.2017.6655 |
Ejemplares similares
-
Effects of immunosuppressants, FK506 and cyclosporin A, on the osteogenic differentiation of rat mesenchymal stem cells
por: Byun, Yu-Kyung, et al.
Publicado: (2012) -
Use of FK506 and bone marrow mesenchymal stem cells for rat hind limb allografts☆
por: Song, Youxin, et al.
Publicado: (2012) -
Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020) -
Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011) -
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992)